Background: Patients with breast cancer have high rates of physical symptoms that
burden is critical for effective palliative care among women treated for breast cancer.
The distress thermometer and problem list (DT&PL) represents an efficient means of capturing distressing physical problems among women across the breast cancer trajectory. This brief measure is endorsed by the National Comprehensive Cancer Network for the identification of psychological distress and to triage symptoms in patients with cancer 7 and is the most broadly accepted and implemented measure of distress internationally, given its convenience and proven acceptability in busy oncology clinics. 8 The physical problem list (PPL) variables that accompany the DT&PL have not been adequately explored for their associations with breast cancer treatments and patient characteristics.
The problem list is meant to be a convenient measure to identify pertinent issues that may or may not be associated with the distress level on the DT&PL. It provides readily accessible information about physical symptomatology. Few studies have tried to determine which physical items are most salient and related to other breast cancer factors, 9, 10 but evidence exists that patient characteristics, such as a history of childhood adversity, affect women's report of physical symptom distress during breast cancer treatment. 11 In order for care to be truly comprehensive, care must adequately address physical symptom burdens, with the first step towards this goal being effective symptom assessment. The efficacy of use of the DT&PL as a physical symptom assessment, as well as an assessment of groups of patients who are more likely to endorse physical symptom on the DT&PL, should therefore be sought.
Given this need, this study will evaluate self-reported physical symptom burden among women receiving care at an outpatient breast cancer clinic using the PPL of the DT&PL and examine whether physical bother differs systematically by patient demographic or medical characteristics. Results will identify groups of women vulnerable to elevated physical symptom distress who may benefit from targeted symptom management interventions and provide information about the feasibility and utility of implementing the DT&PL for capturing patient physical symptom distress in an outpatient clinic. 
| METHODS AND MATERIALS

| Physical problems
Patients endorsed whether a physical symptom had been a problem for them over the past week using the PPL on the DT&PL. The DT&PL has been used widely by cancer institutions to meet the commission on cancer distress-screening mandate for accreditation 12, 13 in 2015. A list of several problem list categories (eg, practical, family, emotional, spiritual/religious, and physical) appears alongside the distress thermometer and are potentially modifiable depending on clinic needs.
The PPL contains 22 separate items (see Table 2 for items), to which patients endorse whether or not a particular physical symptom has been a problem for them in the past week.
| Distress
Patients were evaluated for distress using the DT&PL that was filled out at the same time as the PPL. Distress scores were evaluated for their associations with individual PPL variables and with the total number of endorsed PPL variables by patient.
| Statistical analysis
The primary outcome of this study was the prevalence of 22 PPL The median number of PPL variables endorsed by patients was 3.0 (M = 3.43, SD = 3.42) with a range from 0 to 14 (see Table 2 ).
Approximately one-fourth endorsed no physical symptoms while three-fourths reported at least 1 problem, and three-fifths endorsed 2 or more problems. The 5 most commonly reported physical problems were fatigue (40.0%), sleep (34.7%), skin dry/itchy (22.9%), pain (19.5%), and feeling swollen (19.5%). Problems with changes in urination, fevers, and substance abuse were not common (all <2.5%).
Results of bivariate comparison tests examining the associations
between patient characteristics and endorsement of physical problems are listed in Table 3 . Patients reporting problems of feeling swollen (P = .028), appearance (P = .001), and constipation (P = .013) were younger on average than those not reporting these problems. Race and ethnicity were associated with endorsing problems with skin dry/itchy (P = .009), pain (P = .046), tingling in hands/feet (P = .003), eating (P = .001), constipation (P = .044), and breathing (P = .040). Follow-up planned comparisons were conducted using Keppel's modified Bonferroni correction (α pc = .040) for each significant symptom. Women endorsing other race/ethnicity were 3.9 times more likely to report a problem with skin dry/itchy than black women (.600/.154, (.571/0, χ 2 [1, n = 12] = 4.286, P = .038). There were no other differences between race/ethnicity groups for eating (Ps > .094). Marital status was associated with reporting problems of fatigue (P = .011) and tingling in hands/feet (P = .023). Women not currently married were 1.81 times more likely to report fatigue (.547/.302) and 2.6 times more likely to report tingling in hands/feet (.254/.098).
Employment status was associated with reporting problems of fatigue (P = .012), skin dry/itchy (P = .033), breathing (P = .040), getting around (P = .015), and nausea (P = .026). Women not currently employed were Chemotherapy history was associated with reporting fatigue (P = .035) and nausea (P = .026). Women who reported receiving chemotherapy were 1.7 times more likely to report fatigue (.508/.304) and 4.4 times more likely to report nausea (.159/.036).
Surgery and receipt of antihormones were unrelated to reporting physical problems examined.
The average distress score (DT&PL) was 3.95 (SD = 2.57). Distress was associated with problems with breathing (P = .05), eating (P = .016), memory/concentration (P = .038), and nausea (P = .005) ( Table 4) . Number of physical problems was associated with distress (P = .012).
| DISCUSSION
Over 75% of patients with breast cancer reported at least 1 physical problem, and over half of patients reported 2 or more physical problems. Patients who reported physical problems were younger, nonwhite, unmarried, and/or unemployed. The reasons for these associations are not all together clear. Many of the most common physical problems (eg, fatigue, sleep disturbance, and pain) are associated with psychological symptoms 6 and overall global functioning in these patients. 15 This descriptive study draws attention to the significant physical symptom burden in women with breast cancer, which may be obtained using the DT&PL.
The prevalences of physical problems were similar to those found among studies of women with breast cancer in other nations. Fatigue was most common in a group of German 16 and Korean patients with breast cancer. 17 Both groups found that problems with sleep, tingling in hands/feet, pain, and pruritus were all reported in more than 20%
of women. Correlates of physical symptom burden are also comparable to studies of other breast cancer cohorts 5, 18 and other cancer types. 19 Our findings are also consistent with data that suggest that Latino women express greater symptom burden relative to black/women. 20 This is likely due to poor symptom control in this group, but interpretation of the scale may be another possibility for the discrepancy. In previous studies, Latino women have shown "extreme response tendency," but it is not clear that that would translate to a dichotomous measure. 21 Younger women have been shown to report heavier symptom burden in other cancer scenarios. 22 Women who are unmarried and unemployed may be more likely to lack social and economic support and suffer from physical symptoms.
Results show that the PPL of the DT&PL detects poorly controlled physical symptom burden among women with breast cancer and may be useful in determining groups of women who may particularly benefit from enhanced palliative symptom management. Of note, the total number of endorsed PPL on the DT&PL was associated with distress.
This tool may be used to identify physical symptom burden. Palliation of those PPL variables should help to lower distress levels. Poorly controlled physical symptom burden may reflect a problem with communication about symptoms in the clinic when not using a scale Despite its limitations, the prevalences of physical symptoms reported through the PPL were comparable to those documented among other studies using more comprehensive measures. 26 Given that the PPL is a brief, easily completed accompaniment to the distress thermometer, the most widely implemented distress screening tool in oncology clinics, this measure may be most easily implemented into clinics to regularly assess and improve management of symptom burdens among women with breast cancer. Future research should examine the development of women's physical symptom burden over time through longitudinal study. Furthermore, given the known interrelationship between physical symptoms on psychological symptoms, future work may wish to examine how prevalent physical problems among women with breast cancer related to their psychological health and global functioning.
| CLINICAL IMPLICATIONS
In summary, this study provides preliminary evidence for an association between physical symptom burden and patient demographics using the DT&PL in women with breast cancer. The vast majority of women reported 2 or more physical symptoms that were problematic and thus not adequately controlled. Patients who were younger and nonwhite or Latina reported greater symptom burden, while married women had less problems with fatigue and numbness/tingling.
Unemployed women and those who had received chemotherapy also had greater symptom burden. The DT&PL, widely implemented as a distress-screening instrument, may also be helpful in delineating problematic physical symptomatology in patients with breast cancer.
Future research should focus on groups (younger, nonwhite, unemployed, and not married) with significant associations for these physical symptoms. The development of targeted, effective symptom management strategies for breast cancer patients at highest risk for adverse outcomes from physical problems associated with the disease and treatment will be critical to sustaining the quality of life among this vulnerable population of patients.
